Get started
Arcadia Biosciences, Inc.Arcadia Biosciences, Inc.Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

No trades
OverviewFinancialsNewsDocumentsIdeasMindsTechnicalsSeasonals

Market insights

RKDA | Lets Get It | OversoldArcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
NASDAQ:RKDALong
by DivergenceSeeker
Arcadia Biosciences Rises on Wheat Hype Last Closing Price: $2.62 50-Day Simple Moving Average: $1.10 Volume Weighted Average Price: $2.43 Relative Strength Index: 85.27 20-Day Average Daily Volume: 5,403,900 Shares Outstanding: 22,184,235 Available Borrow: 45,000 Borrow Fee Rate: 40.62% Just a month ago, Arcadia Biosciences, Inc. ( NASDAQ:RKDA ) was a penny stock in danger of delisting. But over the past three weeks, the stock has delivered a series of one-day gains as high as 31%. Today, it closed up 34% at $2.62 per share, its highest price since last July. What’s driving the rally? Maybe investors believe the company will benefit from rising wheat prices caused by sanctions against Russia. Since 2018, Arcadia has sold a line of specialty wheat ingredients for use in consumer packaged goods. But wheat products still account for a small percentage of the company’s total revenue, which isn’t much. As of Sep. 30, Arcadia had earned just $4,609,000 of revenue in the first nine months of 2021, and more than half of that came from acquisitions. In seven years as a publicly traded company, Arcadia has never reported an operating profit or positive cash flow except for a windfall it received in the fourth quarter of 2020 from the sale of its interest in a joint venture. Rather than generating cash, the company has survived on one dilutive stock offering after another. In the process, it has acquired a significant overhang of outstanding warrants with exercise prices below the stock’s current market price. The owners of the warrants aren’t the type to wait patiently. Living hand to mouth A registration statement that Arcadia filed in January reveals a long list of selling shareholders that specialize in financing needy micro-cap companies. And they’re just the ones that participated in Arcadia’s Dec. 2020 private placement . Since 2018, Arcadia has sold stock and warrants in eight offerings, often relying on a $50,000,000 shelf registration filed in May 2018. In two of the financings, investors agreed to exercise warrants they had acquired in prior offerings at reduced exercise prices in exchange for newly issued warrants with even lower exercise prices. Just over four years ago, Arcadia effected a one-for-twenty reverse stock split, reducing its shares outstanding to 2,481,137. As of Dec. 31, 2021, shares outstanding had ballooned to 22,184,235. During the same four-year period, the company’s accumulated deficit swelled from $167,300,000 to $217,203,000, and the market price of its stock sunk from a high of $47.99 per share on Mar. 14, 2018 to a low of $0.78 per share on Jan. 28, 2022. The warrants Arcadia sold during the past four years had exercise prices ranging from $3.00 to $45.75 per share. As of Dec. 31, 2021, Intracoastal Capital, LLC beneficially owned 1,058,559 shares of Arcadia issuable upon exercise of warrants. The market price of Arcadia’s stock would have to rise above $3.00 per share before Intracoastal could profit from selling any shares it acquired from exercising warrants . Motivated sellers At the end of last year, Hudson Bay Capital, LLC beneficially owned 890,049 shares of Arcadia issuable upon exercise of warrants. From Mar. 2018 through Jun. 2019, the hedge fund participated in Arcadia’s offerings of warrants with exercise prices ranging from $5.00 to $45.75 per share. Depending on when they were issued, the warrants expire five and a half years after the issuance date or the initial exercise date. The holders of Arcadia’s warrants have an incentive to bid up the company’s stock price to an amount that will allow them to exercise and sell profitably. We are not suggesting that any of them are manipulating prices or violating securities laws. Regardless, if they begin exercising warrants and liquidating newly issued shares, the sales will put downward pressure on Arcadia’s stock price. That’s why we believe the stock won’t maintain the loftiest prices it reaches in the current rally. As of Sep. 30, 2021, Arcadia had $35,526,000 in cash. But the company used $19,208,000 to fund its operations in the first nine months of last year. At that rate, the company is likely to raise capital again within the next four quarters. Moreover, the company’s 2018 shelf registration has approximately $11,000,000 of remaining capacity, which could allow Arcadia to issue shares available for immediate resale, further diluting shareholders.
NASDAQ:RKDAShort
by shortfinder
Developing TradeWe have a super strong support and unusual volume today. It is an earning play which could help propel the next bull cicle of the stock. Rsi in line with predictions and afterhours activity seem to indicate a nice buildup for a great day. Trade only above breaks and volume must maintain during the day. Wait for flush at open and ride the wave. It breaks support its a shhhh show. For swing trade this is a great entry point once the smoke clears tomorrow. The risk reward raio its perfect..Stop right below support. This stock its full of false breaks so thread carefully. Remeber its a sale the news almost always...unless there is momentum ..volume volume voume, watch pre market to confirm trend its holding.
NASDAQ:RKDALong
by eltraderche
Why $RKDA Skyrocketed yesterdayWhy $RKDA Skyrocketed yesterday There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. $RKDA shares were buoyed — thanks to discussions stock trading groups on Twitter and Twitter hashtags, before the market opened. Hemp/Pot play, Similar to $TLRY move from $3 to $50 has monster upside once it launches. Expect $20 + & a multi day runner The other positive factor for the cannabis industry is the effort in Washington to decriminalize marijuana at the federal level.
NASDAQ:RKDA
by AlenCiken
$RKDAArcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.
NASDAQ:RKDALong
by BADQOMOCAWGOWLD
1
RKDA: Best BUY opportunity during FEBRUARY bear marketFundamentally Arcadia has always done well during bear markets, August 2019 it went from a low of 2.07 to a high of 10.18. Previously in February 2019 it fluctuated from 3.76 to 10.34. Technically we can see a rounding bottom w/ bump turning into a cup with handle (yellow line=handle). after the CUP w/ HANDLE hits it will create an ADAM bottom to accompany the EVE bottom (previously rounding bottom), and we can expect a big BULLISH trend.
NASDAQ:RKDA
by StefanoViacava
Arcadia Biosciences, Symmetrical breakout Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. The company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.
NASDAQ:RKDA
by DEXWireNews